Vaginal yeast infections are very common: roughly 3 out of 4 women will have at least one Candida vulvovaginitis episode in their lifetime, and about half will have at least two. At any given moment, an estimated 5 to 10 percent of women carry Candida without symptoms. Recurrent cases, defined as four or more per year, affect a smaller but meaningful minority.

Candida albicans is a yeast that lives harmlessly on skin and in the mouth, gut, and vagina of most healthy people. The immune system and the local bacterial community normally keep it in check. A yeast infection, medically called vulvovaginal candidiasis, occurs when that balance breaks and Candida overgrows in the vagina, producing itch, discharge, and irritation.

The frequency depends heavily on which population you count. Unselected community samples differ from clinic attendees, pregnant women, and people with diabetes. This explainer separates true prevalence, meaning how many people are affected at a point in time, from incidence, meaning new episodes over time, because conflation of the two drives much of the confusion in shorter summaries.

The overgrowth mechanism

Candida is a commensal, not an invader that must be newly caught. Most women already harbor it. What changes is the local environment that keeps its growth restrained.

Lactobacilli, the dominant bacteria in a healthy vagina, produce lactic acid and maintain an acidic pH near 4. Candida prefers this acidity, so pH alone does not explain overgrowth. The protective effect comes more from competitive exclusion: lactobacilli occupy surfaces and consume nutrients that Candida needs. When lactobacilli decline, Candida can shift from a yeast form into hyphae, threadlike filaments that penetrate tissue and trigger inflammation.

Estrogen raises vaginal glycogen, which Candida can metabolize. That is why reproductive-age women are affected far more than prepubertal girls or postmenopausal women without hormone therapy. Antibiotics suppress lactobacilli and other flora, removing competitive pressure. Pregnancy combines high estrogen, altered immunity, and increased glycogen, raising both carriage and symptomatic episodes. Poorly controlled diabetes increases glucose in secretions, feeding yeast directly.

The vaginal immune response also matters. Local antibodies and inflammatory signaling usually contain Candida. Conditions that blunt this response, including immunosuppression, raise both frequency and severity. A plain-language summary: the yeast is usually present, and the question is whether the body keeps it contained.

Quantified context: how often it actually happens

Lifetime figures are the most cited and the most stable. Approximately 75 percent of women experience at least one episode of vulvovaginal candidiasis, and roughly 40 to 50 percent have two or more. Recurrent vulvovaginal candidiasis, defined as at least four symptomatic episodes in 12 months, affects an estimated 5 to 8 percent of women of reproductive age.

Asymptomatic carriage is common and often mistaken for infection. In community studies, around 10 to 20 percent of women test positive for Candida on culture without any symptoms. This matters clinically: a positive culture alone does not diagnose a yeast infection.

Candida albicans causes the large majority of episodes, commonly cited at 80 to 90 percent. The remainder involve other species, notably Candida glabrata, which is harder to treat and more often associated with recurrence. Among women with recurrent infection, non-albicans species appear more frequently.

Timeline: from colonization to recurrence

Stage Typical timing What happens
Exposure and colonization Early life onward Candida establishes harmlessly on mucosa
First symptomatic episode Often reproductive years Overgrowth triggers itch and discharge
Single episode resolution Days to about two weeks Symptoms ease with or without treatment
Second episode Variable, often within a year Repeat overgrowth after new trigger
Recurrent pattern 4+ episodes in 12 months Defined as recurrent candidiasis
Specialist evaluation After recurrence Culture confirms species and alternatives ruled out
Non-albicans shift Sometimes with recurrence C. glabrata and others more likely

These intervals are general patterns, not fixed schedules. Individual timing varies widely, and no single trigger explains most recurrences.

Why counting is harder than it looks

Prevalence estimates swing depending on the denominator. A study of women in a general clinic waiting room yields different numbers than a study of women presenting with itching. Self-reported history overestimates confirmed infection: a substantial share of women who believe they have a yeast infection actually have bacterial vaginosis or another condition.

Diagnosis also biases counts. Symptomatic women seek care and get counted; asymptomatic carriers do not. Culture detects Candida but cannot by itself prove it is causing symptoms. Surveys asking about "yeast infections" mix confirmed diagnoses with presumptive ones.

The counterintuitive detail: because carriage is so common, the presence of Candida is a weak signal. Clinicians weigh symptoms, pH, and microscopy together rather than treating a positive culture as proof. A woman can carry yeast for years and never develop symptoms.

Common misconceptions

One widespread belief is that yeast infections are sexually transmitted. Candida can be shared between partners, but it is not classified as a sexually transmitted infection, and treating partners is not routinely recommended.

Another misconception is that all vaginal discharge and itch indicate yeast. Bacterial vaginosis, trichomoniasis, and irritant or allergic reactions produce overlapping symptoms. Misdiagnosis is common and leads to ineffective treatment.

A third is that recurrent infections mean poor hygiene or a single hidden trigger. Recurrence usually reflects host factors, species differences, or immune variation rather than hygiene failure.

Practical actions

Situation Reasonable step Threshold or note
First suspected episode See a clinician or use an approved self-test Confirm before treating
Symptoms persist after treatment Re-evaluate Persistent symptoms warrant culture
Four or more episodes per year Ask about recurrent management Meets recurrence definition
Diabetes present Optimize glucose control Glucose drives yeast growth
Unusual discharge or odor Get evaluated May not be yeast
Pregnancy Consult a clinician before treating Product choice differs

Seek care promptly for fever, pelvic pain, or foul odor, which suggest something other than uncomplicated yeast. Get evaluated if symptoms do not improve after standard treatment. Ask for culture if episodes recur, to identify non-albicans species. Avoid repeated self-treatment without confirmation, which can mask other conditions. Discuss glucose control if diabetes coexists. Do not assume a partner needs treatment; it is not routinely recommended.

Over-the-counter antifungal products are widely available, but confirm the diagnosis first. Repeated presumptive treatment without confirmation is a common and avoidable error.

Limitations and what the numbers cannot tell you

Population statistics describe groups, not individuals. A 75 percent lifetime figure does not predict any one person's course. Estimates also vary by region, age group, and diagnostic criteria, so ranges are more trustworthy than single numbers.

Much of the strongest data predates recent diagnostic shifts, and definitions of recurrence differ across sources. Symptomatic versus asymptomatic counts are frequently blended in popular summaries, inflating apparent frequency. Where sources conflict, this explainer favors ranges and states the definition rather than asserting a single figure.

Candida species distribution and recurrence rates are stable biological patterns, but exact percentages should be treated as approximations. Anyone with persistent, recurrent, or atypical symptoms should seek clinical evaluation rather than rely on general statistics.